Ophthalmology Times: July 15, 2021

August 25, 2021

Investigation evaluates safety of single and multiple intravitreal injections.

August 24, 2021

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

August 23, 2021

Advances help gain clearer image, enhancing decision-making process.

August 20, 2021

Patients can try different drops and dosing schedules to improve outcomes.

August 19, 2021

Systemic immunosuppression may prevent devastating complication in patients.

August 18, 2021

GT005 designed to induce local production of recombinant complement factor I.

August 17, 2021

CAM’s regenerative healing means long-term relief and fewer visits to clinic.

August 16, 2021

Philip Rosenfeld, MD, PhD, presents results from a natural history study of patients that results in recognition of hypertransmission defects on en face OCT.

August 13, 2021

Cotargeted therapy could help combat inherited retinal diseases.

August 12, 2021

Tool for quantifying measures may predict outcomes for patients.

August 11, 2021

Substantial weight loss can help patients’ eye health, study results show.

July 12, 2021

The primary barriers to COVID-19 vaccine development are manufacturing constraints.

July 11, 2021

Two trials examine factors affecting the risk of disease.